A healthy lifestyle is the cornerstone of prevention. Its promotion is a major task for all healthcare providers with the collaboration of the family and caregivers. It includes intervention in personal behaviour and risk factors (such as lack of physical activity, use of tobacco, unhealthy food habits and overweight), and all interventions aimed at changing lifestyle should be lifelong.
PiepoliMFHoesAWAgewallS. Authors/Task Force Members. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention and Rehabilitation (EACPR). Eur J Prev Cardiol2016; 23: NP1–NP96.
2.
ArtinianNTFletcherGFMozaffarianD. Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation2010; 122: 406–441.
RubakSSandbaekALauritzenT. Motivational interviewing: a systematic review and meta-analysis. Br J Gen Pract: The journal of the Royal College of General Practitioners2005; 55: 305–312.
5.
BaladyGJWilliamsMAAdesPA. Core components of cardiac rehabilitation/secondary prevention programs: 2007 update: a scientific statement from the American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee, the Council on Clinical Cardiology; the Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, and Metabolism; and the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation2007; 115: 2675–2682.
6.
PiepoliMFCorraUBenzerW. Secondary prevention through cardiac rehabilitation: from knowledge to implementation. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil2010; 17: 1–17.
7.
LeeIMShiromaEJLobeloF. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet2012; 380: 219–229.
8.
LollgenHBockenhoffAKnappG. Physical activity and all-cause mortality: an updated meta-analysis with different intensity categories. Int J Sports Med2009; 30: 213–224.
9.
U.S. Department of Health and Human Services. Physical Activity Guidelines Advisory Committee Report. 2008, https://health.gov/paguidelines/report/ (accessed 3 April 2017).
10.
TalbotLAMorrellCHFlegJL. Changes in leisure time physical activity and risk of all-cause mortality in men and women: the Baltimore Longitudinal Study of Aging. Prev Med2007; 45: 169–176.
11.
PiepoliMFDavosCFrancisDP. Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ2004; 328: 189–189.
12.
LeeDCPateRRLavieCJ. Leisure-time running reduces all-cause and cardiovascular mortality risk. J Am Coll Cardiol2014; 64: 472–481.
13.
MooreSCPatelAVMatthewsCE. Leisure time physical activity of moderate to vigorous intensity and mortality: a large pooled cohort analysis. PLoS Med2012; 9: e1001335–e1001335.
14.
SattelmairJPertmanJDingEL. Dose response between physical activity and risk of coronary heart disease: a meta-analysis. Circulation2011; 124: 789–795.
15.
FletcherGFAdesPAKligfieldP. Exercise standards for testing and training: a scientific statement from the American Heart Association. Circulation2013; 128: 873–934.
16.
HowleyET. Type of activity: resistance, aerobic and leisure versus occupational physical activity. Med Sci Sports Exerc2001; 33(6 Suppl): S364–S369. discussion S419–S420.
17.
DollRPetoRBorehamJ. Mortality in relation to smoking: 50 years’ observations on male British doctors. BMJ2004; 328: 1519–1519.
18.
KiiskinenUVartiainenEPuskaP. Long-term cost and life-expectancy consequences of hypertension. J Hypertens1998; 16: 1103–1112.
19.
PrescottEHippeMSchnohrP. Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ1998; 316: 1043–1047.
20.
KotsevaKWoodDDe BackerG. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil2009; 16: 121–137.
21.
PrescottEScharlingHOslerM. Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12,149 men and women in the Copenhagen City Heart Study. J Epidemiol Commun Health2002; 56: 702–706.
22.
CritchleyJCapewellS. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev2004; (1): CD003041–CD003041.
23.
RohaniMAgewallS. Oral snuff impairs endothelial function in healthy snuff users. J Intern Med2004; 255: 379–383.
24.
US Department of Health and Human Services. How tobacco smoke causes disease: The biology and behavioural basis for smoking-attributable disease 2010. Reports of the Surgeon General, US Public Health Service, http://www.surgeongeneral.gov/library/tobaccosmoke/index.html (accessed 30 March 2017).
25.
HeJVupputuriSAllenK. Passive smoking and the risk of coronary heart disease – a meta-analysis of epidemiologic studies. N Engl J Med1999; 340: 920–926.
26.
LawMRMorrisJKWaldNJ. Environmental tobacco smoke exposure and ischaemic heart disease: an evaluation of the evidence. BMJ1997; 315: 973–980.
27.
JosephAMNormanSMFerryLH. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med1996; 335: 1792–1798.
28.
ChowCKJollySRao-MelaciniP. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation2010; 121: 750–758.
HeathertonTFKozlowskiLTFreckerRC. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire. Br J Addiction1991; 86: 1119–1127.
BullenCHoweCLaugesenM. Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet2013; 382: 1629–1637.
34.
HenningfieldJE. Nicotine medications for smoking cessation. N Engl J Med1995; 333: 1196–1203.
35.
EH Network. Diet, physical activity and cardiovascular disease prevention in Europe, Brussels, Belgium: EHN, 2011.
36.
MozaffarianDKatanMBAscherioA. Trans fatty acids and cardiovascular disease. N Engl J Med2006; 354: 1601–1613.
37.
HeFJMacGregorGA. Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health. J Hum Hypertens2002; 16: 761–770.
38.
SacksFMSvetkeyLPVollmerWM. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH–Sodium Collaborative Research Group. N Engl J Med2001; 344: 3–10.
39.
AburtoNJHansonSGutierrezH. Effect of increased potassium intake on cardiovascular risk factors and disease: systematic review and meta-analyses. BMJ2013; 346: f1378–f1378.
40.
ThreapletonDEGreenwoodDCEvansCE. Dietary fibre intake and risk of cardiovascular disease: systematic review and meta-analysis. BMJ2013; 347: f6879–f6879.
41.
ZhangZXuGLiuD. Dietary fiber consumption and risk of stroke. Eur J Epidemiol2013; 28: 119–130.
42.
YaoBFangHXuW. Dietary fiber intake and risk of type 2 diabetes: a dose–response analysis of prospective studies. Eur J Epidemiol2014; 29: 79–88.
43.
WangXOuyangYLiuJ. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ2014; 349: g4490–g4490.
44.
HeFJNowsonCAMacGregorGA. Fruit and vegetable consumption and stroke: meta-analysis of cohort studies. Lancet2006; 367: 320–326.
45.
DauchetLAmouyelPHercbergS. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr2006; 136: 2588–2593.
46.
ZhengJHuangTYuY. Fish consumption and CHD mortality: an updated meta-analysis of seventeen cohort studies. Public Health Nutr2012; 15: 725–737.
47.
ChowdhuryRKunutsorSVitezovaA. Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies. BMJ2014; 348: g1903–g1903.
48.
RonksleyPEBrienSETurnerBJ. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ2011; 342: d671–d671.
49.
HolmesMVDaleCEZuccoloL. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ2014; 349: g4164–g4164.
